Agents and methods for the treatment of proliferative diseases
申请人:——
公开号:US20030229026A1
公开(公告)日:2003-12-11
The present invention provides selective kinase inhibitors of formula (I).
1
这项发明提供了式(I)的选择性激酶抑制剂。
Synthesis of 1,7-annulated indoles and their applications in the studies of cyclin dependent kinase inhibitors
作者:Guoxin Zhu、Scott E. Conner、Xun Zhou、Ho-Kit Chan、Chuan Shih、Thomas A. Engler、Rima S. Al-awar、Harold B. Brooks、Scott A. Watkins、Charles D. Spencer、Richard M. Schultz、Jack A. Dempsey、Eileen L. Considine、Bharvin R. Patel、Catherine A. Ogg、Vasu Vasudevan、Michelle L. Lytle
DOI:10.1016/j.bmcl.2004.04.033
日期:2004.6
The synthesis of a novel series of 1,7-annulated indolocarbazoles 2 and 16 is described. These compounds were found to be potent cyclin dependent kinase inhibitors with good antiproliferative activity against two human carcinoma cell lines. These inhibitors also arrested tumor cells at the G1 phase and inhibited pRb phosphorylation. (C) 2004 Elsevier Ltd. All rights reserved.